Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Deutsche Krebsgesellschaft (DKG), Deutsche Krebshilfe. Brustkrebs II: Die fortgeschrittene Erkrankung, Rezidiv und Metastasierung. (Leitlinienprogramm Onkologie, in Überarbeitung). AWMF-Registernr.: 032-045OL. 2011.
Beckermann MJ. Die ambulante Begleitung von Frauen nach Krebserkrankungen. In: Beckermann MJ, Perl FM (Ed). Frauen-Heilkunde und Geburts-Hilfe. Basel: Schwabe; 2004. P. 1694-1700.
Butow PN, Dowsett S, Hagerty R et al. Communicating prognosis to patients with metastatic disease: what do they really want to know? Support Care Cancer 2002; 10(2): 161-168.
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), Deutsche Krebsgesellschaft (DKG). Interdisziplinäre S3-Leitlinie für die Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms. AWMF-Registernr.: 032-045OL. 2021.
Kenne Sarenmalm E, Thoren-Jonsson AL, Gaston-Johansson F et al. Making sense of living under the shadow of death: adjusting to a recurrent breast cancer illness. Qual Health Res 2009; 19(8): 1116-1130.
Kommission Mamma der Arbeitsgemeinschaft Gynäkologische Gynäkologie (AGO), Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), Deutsche Krebsgesellschaft (DKG). Diagnostik und Therapie von Patientinnen mit primärem und metastasiertem Brustkrebs. 2023.
Lewis S, Yee J, Kilbreath S et al. A qualitative study of women's experiences of healthcare, treatment and support for metastatic breast cancer. Breast 2015; 24(3): 242-247.
Lück HJ. Systemische Therapie des metastasierten Mammakarzinoms. In: Kreienberg R, Möbus V, Jonat W et al. (Ed). Mammakarzinom: interdisziplinär. Berlin: Springer; 2010. P. 228-246.
National Institute for Health and Care Excellence (NICE). Advanced Breast Cancer: Diagnosis and Treatment. (NICE Clinical Guidelines; No. 81). 2017.
Svensson H, Brandberg Y, Einbeigi Z et al. Psychological reactions to progression of metastatic breast cancer: an interview study. Cancer Nurs 2009; 32(1): 55-63.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.